Medipharm Labs Corp T.LABS

Inventory write down???

[alleyesonme]

Last financials labs reported a large amount of inventory. I think it was close to 30 mil. I believe oils have an exp date of 14 to 24 months and dried pills longer. This inventory in my mind is great to have on hand as long as it's being properly managed and cycled out the door. Is anyone worried about writedowns (inventory being accounted for as less valuable as it once was). I'm not so concerned about it but maybee I should be. Opinions. Thanks.

[lscfa]

let's hope the 550% increase in unit sales took care of it. Or maybe they shipped it off to Australia.  

[lscfa]

    Starting Inventory Buy Sell Write down Ending inventory Ending Raw material Ending Finished goods Dec 19        

[alleyesonme]

Thanks. It sounds to me like it's a quarterly accounting practice. And at the end of the quarter they write down the cost of the inventory remaining. The remaining inventory may be sold the following quarter and the cycle continues. So it's not like the remainder is being sold at a discount or carted out to the dumpster. Those are my thoughts correct me if I'm wrong.

[allibabba]

I'm going to get jumped on here but I'll post my thought in case some want to read.  First it's 550 units shipped not 550%.  It was said that there was a 200% increase in SHIPMENTS in Q4, not revenue increase.  Just my take from it.  Yes it's going in the right direction but the key word in the release was shipments.  There might not be that much revenue in

[Lemoyne]

Write down = revenue loss, in this case because the market prices are going down. There is no positive way to turn this. This is a consequence of immature market where prices are changing so much a write down has to be taken. There are still write downs possible (i would say more than likely), but hopefully, intl growth will gobble up most of the inventory LABS stocks. I do think it really boils

[alleyesonme]

Ahhh clarity. Thanks for that. I to am optimistic about international business soaking up inventory. Stada's potential is far bigger than given credit for not to mention the dozens of other distribution deals around the world. Their will come a time when international business exceeds domestic. It may be sooner than we think. Update will be impressive I think. When we will hear anyones guess

[bitscounter]

Just wondering, are there any plans for LABS partnering with US pharmaceuticals or US MSO's? We keep hearing about European/Australian partners but none in the US so far.

[Righttothetop]

Just a hunch, but I expect that LABS focused on jurisdictions that had greater clarity in their approach to this sector.  The US really didn't have any consistent or universal approval/approach. I would expect that they have been in talks with Stada like outfits in the US....but who knows. After the Stada deal, I really did (and do) hope that a like deal in the US is in the works. 

[lscfa]

Mexico might be a better bet.....

[Righttothetop]

Incidentally, Valens is taking a sheet kicking for, among other things, doing the exact same thing that LABS did end of last year....sure they did a financing and gobbled someone up, but the impact is the same. Some might say that the LABS mgmt team got ahead of this and did a decent job at righting the ship early....I do recall a number of persons on many forums stomping all over LABS and

[lscfa]

CBD legalization in Europe may speed up Stada launch....   November, 24 2020 - Sativa Wellness Group Inc. (CSE: SWEL) wishes to announce that following the European Court of Justice (the "ECJ") has ruled that cannabidiol ("CBD") is not a classified as a narcotic drug. The Company is on track for the submission deadline in March 2021 to the UK FSA Novel Foods